Katarzyna Kusmierz

Biography

Katarzyna Kusmierz is a Director of BioMarker Strategies and Chairman of the Supervisory Board and Chief Executive Officer of USP Group, which includes USP Zdrowie, Poland’s leading OTC/Consumer Health pharmaceutical company. USP Zdrowie product lines include Cold & Flu, Pain, Energy, Digestive Health, Joint Relief and other indications. A number of the USP Zdrowie products are the leaders of their categories in Poland. Ms. Kusmierz has been with USP Group almost since its creation 20 years ago. She has held a series of operational and supervisory roles of increasing responsibility, and worked with USP Group Founders on corporate structure, tax and regulatory issues, as well as financial and strategic planning. She also serves as President of US Pharmacia International, Inc., which is the center of the company’s U.S. operations, as well as financial and legal headquarters of the USP Group. In her capacity as Chairman of the Supervisory Board, Ms. Kusmierz helped define USP Group’s mission and vision as a promotor of health and wellness among Polish consumers. A major element of this was the rebranding campaign that led to the creation of USP Zdrowie, Polish for Health – one of the most recognizable names in pharmaceuticals among consumers in Poland. Ms. Kusmierz has also led USP Group to expand its efforts into investing into early stage biotech companies through its US investing entity, Novit LP, as well as in Poland through another affiliated entity, and sees such investments as a significant part of the Group’s growth plans going forward. She studied at the Department of Economics at the University of Gdansk, Poland, focusing on international trade.

Research Interest

Katarzyna Kusmierz is a Director of BioMarker Strategies and Chairman of the Supervisory Board and Chief Executive Officer of USP Group, which includes USP Zdrowie, Poland’s leading OTC/Consumer Health pharmaceutical company. USP Zdrowie product lines include Cold & Flu, Pain, Energy, Digestive Health, Joint Relief and other indications. A number of the USP Zdrowie products are the leaders of their categories in Poland. Ms. Kusmierz has been with USP Group almost since its creation 20 years ago. She has held a series of operational and supervisory roles of increasing responsibility, and worked with USP Group Founders on corporate structure, tax and regulatory issues, as well as financial and strategic planning. She also serves as President of US Pharmacia International, Inc., which is the center of the company’s U.S. operations, as well as financial and legal headquarters of the USP Group. In her capacity as Chairman of the Supervisory Board, Ms. Kusmierz helped define USP Group’s mission and vision as a promotor of health and wellness among Polish consumers. A major element of this was the rebranding campaign that led to the creation of USP Zdrowie, Polish for Health – one of the most recognizable names in pharmaceuticals among consumers in Poland. Ms. Kusmierz has also led USP Group to expand its efforts into investing into early stage biotech companies through its US investing entity, Novit LP, as well as in Poland through another affiliated entity, and sees such investments as a significant part of the Group’s growth plans going forward. She studied at the Department of Economics at the University of Gdansk, Poland, focusing on international trade.